2025
SJR Q1
JCR Q1 · 14,7
OA
12 matched articles
SCIE
Journal detail
Drugs
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
0012666711791950
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 3,5
- Quartile Q1
- H-Index 212
- Cites/doc 13,28
- Docs (3y) 408
- Cites (3y) 5.214
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 14,7
- 5Y JIF 14,4
- JCI 2,82
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology (medical) Q1
Areas
- Medicine
WoS categories
- Pharmacology & Pharmacy | Toxicology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 3,5 | 14,7 | 14,4 | 2,82 | Q1 | 212 |
| 2024 | Q1 | Q1 | 3,362 | 14,4 | 13,2 | 3,22 | Q1 | 201 |
| 2023 | Q1 | Q1 | 2,352 | 13 | 11,4 | 3 | Q1 | 201 |
| 2022 | Q1 | Q1 | 2,093 | 11,5 | 10,5 | 2,5 | Q1 | 201 |
| 2021 | Q1 | Q1 | 2,081 | 11,4 | 9,9 | 2,24 | Q1 | 201 |
| 2020 | Q1 | Q1 | 2,022 | 9,5 | 7,6 | 1,86 | Q1 | 201 |
| 2019 | Q1 | Q1 | 1,589 | 6,2 | 5,3 | 1,52 | Q1 | 201 |
| 2018 | — | Q1 | — | 5 | 4,6 | 1,43 | Q1 | — |
| 2017 | Q1 | Q1 | 1,547 | 4,7 | 4,4 | 1,48 | Q1 | 201 |
| 2016 | Q1 | Q1 | 1,588 | 5 | 4,4 | — | — | 201 |
| 2015 | Q1 | Q1 | 1,683 | 4,9 | 4,3 | — | — | 201 |
| 2014 | Q1 | Q1 | 1,672 | 4,3 | 4,1 | — | — | 201 |
| 2013 | Q1 | Q1 | 1,48 | 4,1 | 3,8 | — | — | 201 |
| 2012 | Q1 | Q1 | 1,615 | 4,6 | 4,1 | — | — | 201 |
| 2011 | Q1 | Q1 | 1,49 | 4,2 | 3,7 | — | — | 201 |
| 2010 | Q1 | Q1 | 1,357 | 3,7 | 3,6 | — | — | 201 |
| 2009 | — | Q1 | — | 4,7 | 4 | — | — | — |
| 2008 | — | Q1 | — | 4,1 | 4,2 | — | — | — |
| 2007 | — | Q1 | — | 3,7 | 4 | — | — | — |
| 2006 | — | Q1 | — | 4,5 | — | — | — | — |
| 2005 | — | Q1 | — | 4,5 | — | — | — | — |
| 2004 | — | Q1 | — | 4,4 | — | — | — | — |
| 2003 | — | Q1 | — | 4,6 | — | — | — | — |
| 2002 | — | Q1 | — | 5,4 | — | — | — | — |
| 2001 | — | Q1 | — | 4,4 | — | — | — | — |
| 2000 | — | Q1 | — | 4 | — | — | — | — |
| 1999 | — | Q1 | — | 4,2 | — | — | — | — |
| 1998 | — | Q1 | — | 3,2 | — | — | — | — |
| 1997 | — | Q1 | — | 3,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 7/356 |
| 2025 | TOXICOLOGY | SCIE | Q1 | Q1 | 2/106 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 7/352 |
| 2024 | TOXICOLOGY | SCIE | Q1 | Q1 | 1/106 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 7/354 |
| 2023 | TOXICOLOGY | SCIE | Q1 | Q1 | 1/106 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 10/278 |
| 2022 | TOXICOLOGY | SCIE | Q1 | Q1 | 2/94 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 13/279 |
| 2021 | TOXICOLOGY | SCIE | Q1 | Q1 | 2/94 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 11/276 |
| 2020 | TOXICOLOGY | SCIE | Q1 | Q1 | 2/93 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 17/271 |
| 2019 | TOXICOLOGY | SCIE | Q1 | Q1 | 5/92 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 23/267 |
| 2018 | TOXICOLOGY | SCIE | Q1 | Q1 | 10/93 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 24/261 |
| 2017 | TOXICOLOGY | SCIE | Q1 | Q1 | 10/94 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 25/257 |
| 2016 | TOXICOLOGY | SCIE | Q1 | — | 9/92 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 24/255 |
| 2015 | TOXICOLOGY | SCIE | Q1 | — | 9/90 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 32/255 |
| 2014 | TOXICOLOGY | SCIE | Q1 | — | 9/88 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 33/256 |
| 2013 | TOXICOLOGY | SCIE | Q1 | — | 13/87 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 27/261 |
| 2012 | TOXICOLOGY | SCIE | Q1 | — | 7/85 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 38/261 |
| 2011 | TOXICOLOGY | SCIE | Q1 | — | 11/83 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 51/252 |
| 2010 | TOXICOLOGY | SCIE | Q1 | — | 14/83 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 25/237 |
| 2009 | TOXICOLOGY | SCIE | Q1 | — | 5/77 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 36/219 |
| 2008 | TOXICOLOGY | SCIE | Q1 | — | 6/75 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 43/205 |
| 2007 | TOXICOLOGY | SCIE | Q1 | — | 8/73 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 25/199 |
| 2006 | TOXICOLOGY | SCIE | Q1 | — | 5/76 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 23/193 |
| 2005 | TOXICOLOGY | SCIE | Q1 | — | 5/75 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 21/187 |
| 2004 | TOXICOLOGY | SCIE | Q1 | — | 2/75 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 17/185 |
| 2003 | TOXICOLOGY | SCIE | Q1 | — | 3/77 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 10/188 |
| 2002 | TOXICOLOGY | SCIE | Q1 | — | 3/76 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 13/186 |
| 2001 | TOXICOLOGY | SCIE | Q1 | — | 5/78 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 16/181 |
| 2000 | TOXICOLOGY | SCIE | Q1 | — | 4/77 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 14/175 |
| 1999 | TOXICOLOGY | SCIE | Q1 | — | 3/74 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 18/178 |
| 1998 | TOXICOLOGY | SCIE | Q1 | — | 4/71 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 17/157 |
| 1997 | TOXICOLOGY | SCIE | Q1 | — | 3/63 |